Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Anti-Obesity Drugs Market, by Drug Type
1.4.2 LAMEA Anti-Obesity Drugs Market, by Mechanism of Action
1.4.3 LAMEA Anti-Obesity Drugs Market, by Route Of Administration
1.4.4 LAMEA Anti-Obesity Drugs Market, by Distribution Channel
1.4.5 LAMEA Anti-Obesity Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Anti-Obesity Drugs Market by Drug Type
3.1 LAMEA Prescription Drugs Market by Country
3.2 LAMEA Over The Counter Drugs Market by Country
Chapter 4. LAMEA Anti-Obesity Drugs Market by Mechanism of Action
4.1 LAMEA Centrally Acting Market by Country
4.2 LAMEA Peripherally Acting Market by Country
Chapter 5. LAMEA Anti-Obesity Drugs Market by Route Of Administration
5.1 LAMEA Oral Route Market by Country
5.2 LAMEA Subcutaneous Route Market by Country
Chapter 6. LAMEA Anti-Obesity Drugs Market by Distribution Channel
6.1 LAMEA Hospital Pharmacies Market by Country
6.2 LAMEA Retail Pharmacies Market by Country
6.3 LAMEA Online Pharmacies Market by Country
Chapter 7. LAMEA Anti-Obesity Drugs Market by Country
7.1 Brazil Anti-Obesity Drugs Market
7.1.1 Brazil Anti-Obesity Drugs Market by Drug Type
7.1.2 Brazil Anti-Obesity Drugs Market by Mechanism of Action
7.1.3 Brazil Anti-Obesity Drugs Market by Route Of Administration
7.1.4 Brazil Anti-Obesity Drugs Market by Distribution Channel
7.2 Argentina Anti-Obesity Drugs Market
7.2.1 Argentina Anti-Obesity Drugs Market by Drug Type
7.2.2 Argentina Anti-Obesity Drugs Market by Mechanism of Action
7.2.3 Argentina Anti-Obesity Drugs Market by Route Of Administration
7.2.4 Argentina Anti-Obesity Drugs Market by Distribution Channel
7.3 UAE Anti-Obesity Drugs Market
7.3.1 UAE Anti-Obesity Drugs Market by Drug Type
7.3.2 UAE Anti-Obesity Drugs Market by Mechanism of Action
7.3.3 UAE Anti-Obesity Drugs Market by Route Of Administration
7.3.4 UAE Anti-Obesity Drugs Market by Distribution Channel
7.4 Saudi Arabia Anti-Obesity Drugs Market
7.4.1 Saudi Arabia Anti-Obesity Drugs Market by Drug Type
7.4.2 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action
7.4.3 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration
7.4.4 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel
7.5 South Africa Anti-Obesity Drugs Market
7.5.1 South Africa Anti-Obesity Drugs Market by Drug Type
7.5.2 South Africa Anti-Obesity Drugs Market by Mechanism of Action
7.5.3 South Africa Anti-Obesity Drugs Market by Route Of Administration
7.5.4 South Africa Anti-Obesity Drugs Market by Distribution Channel
7.6 Nigeria Anti-Obesity Drugs Market
7.6.1 Nigeria Anti-Obesity Drugs Market by Drug Type
7.6.2 Nigeria Anti-Obesity Drugs Market by Mechanism of Action
7.6.3 Nigeria Anti-Obesity Drugs Market by Route Of Administration
7.6.4 Nigeria Anti-Obesity Drugs Market by Distribution Channel
7.7 Rest of LAMEA Anti-Obesity Drugs Market
7.7.1 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type
7.7.2 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action
7.7.3 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration
7.7.4 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.2 Boehringer Ingelheim International Gmbh
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 GlaxoSmithKline PLC (GSK)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Novo Nordisk A/S
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental & Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Rhythm Pharmaceuticals, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Gelesis Holdings Inc (PureTech Health)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.4.2 Approvals and Trials:
8.7 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Acquisition and Mergers:
8.8 Vivus LLC
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Approvals and Trials:
8.9 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
8.9.1 Company Overview
8.10. KVK Tech, Inc.
8.10.1 Company Overview
Unique Offerings 